[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CO5780137A1 - Antigenos protectores y vacunas para el control de infestaciones por multiespecies de garrapatas - Google Patents

Antigenos protectores y vacunas para el control de infestaciones por multiespecies de garrapatas

Info

Publication number
CO5780137A1
CO5780137A1 CO06077106A CO06077106A CO5780137A1 CO 5780137 A1 CO5780137 A1 CO 5780137A1 CO 06077106 A CO06077106 A CO 06077106A CO 06077106 A CO06077106 A CO 06077106A CO 5780137 A1 CO5780137 A1 CO 5780137A1
Authority
CO
Colombia
Prior art keywords
seq
multiespecies
protectives
infestations
tickets
Prior art date
Application number
CO06077106A
Other languages
English (en)
Inventor
La Fuente Jose De Jesus De
Katherine M Kocan
Almazan Consuelo Garcia
Edmour F Blouin
Original Assignee
Univ Oklahoma State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oklahoma State filed Critical Univ Oklahoma State
Publication of CO5780137A1 publication Critical patent/CO5780137A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un polipéptido aislado, caracterizado porque comprende una secuencia de aminoácidos mostrada en las SEQ ID NOS: 52 hasta 62, SEQ ID NO: 4, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 o SEQ ID NO: 39, o un polipéptido aislado que comprende una secuencia de aminoácidos que es por lo menos 60% homóloga a por lo menos una de las SEQ ID NOS: 52 hasta 62, SEQ ID NO: 4, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 o SEQ ID NO: 39. Una composición de vacuna anti-garrapata multiespecies, caracterizada porque comprende un polipéptido de la reivindicación 1 y un portador o diluyente farmacéuticamente aceptable. Una composición de vacuna de conformidad con la reivindicación 2, caracterizada porque la composición comprende más de uno de los polipéptidos de acuerdo a la reivindicación 1.
CO06077106A 2005-08-04 2006-08-04 Antigenos protectores y vacunas para el control de infestaciones por multiespecies de garrapatas CO5780137A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/197,133 US20060040361A1 (en) 2002-04-29 2005-08-04 Protective antigens and vaccines for the control of multi species tick infestations

Publications (1)

Publication Number Publication Date
CO5780137A1 true CO5780137A1 (es) 2007-07-31

Family

ID=37487552

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06077106A CO5780137A1 (es) 2005-08-04 2006-08-04 Antigenos protectores y vacunas para el control de infestaciones por multiespecies de garrapatas

Country Status (5)

Country Link
US (1) US20060040361A1 (es)
EP (1) EP1749835A3 (es)
BR (1) BRPI0604365A (es)
CO (1) CO5780137A1 (es)
MX (1) MXPA06008962A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123554A1 (en) * 2002-04-29 2005-06-09 The Board Of Regents For Oklahoma State University Protective antigens and vaccines for the control of multi species tick infestations
BRPI0822760B1 (pt) * 2008-06-03 2017-12-19 Vallée S.A Immunogens for the control of bovine carraps
ES2643031T3 (es) * 2013-03-29 2017-11-21 Intervet International B.V. Vacuna contra garrapatas de Rhipicephalus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447537A (en) * 1981-01-22 1984-05-08 The United States Of Americas As Represented By The Department Of Health And Human Services Tick cell lines
US5587311A (en) * 1986-11-27 1996-12-24 Biotechnology Australia Pty. Ltd. DNA encoding a cell membrane glycoprotein of a tick gut
US6235283B1 (en) * 1986-11-27 2001-05-22 Biotechnology Australia Pty. Ltd. DNA encoding a cell membrane glycoprotein of a tick gut
US5344645A (en) * 1991-03-22 1994-09-06 Center For Innovation And Business Development Foundation Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom
WO1997015600A1 (en) * 1995-10-26 1997-05-01 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Tick (ixodes scapularis) vector saliva-induced lyme disease spirochete (borrelia burgdorferi) antigens as vaccine candidates
CA2405537C (en) * 2000-04-25 2012-06-26 Evolutec Limited Vaccine comprising a tick cement protein
US20050123554A1 (en) * 2002-04-29 2005-06-09 The Board Of Regents For Oklahoma State University Protective antigens and vaccines for the control of multi species tick infestations
WO2003093416A2 (en) * 2002-04-29 2003-11-13 The Board Of Regents For Oklahoma State University Protective antigens for the control of ixodes species infestations

Also Published As

Publication number Publication date
EP1749835A3 (en) 2007-09-19
BRPI0604365A (pt) 2007-03-27
US20060040361A1 (en) 2006-02-23
EP1749835A2 (en) 2007-02-07
MXPA06008962A (es) 2007-03-28

Similar Documents

Publication Publication Date Title
ES2558330T3 (es) Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo
ES2536974T3 (es) Péptidos de epítopos del receptor de EGF y usos de los mismos
NO20063026L (no) Antistoffer
ES2542853T3 (es) Método para tratar miastenia grave
PE20110310A1 (es) Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas
AR077096A1 (es) Toxinas cry insecticidas dig-11 de bacillus thuringiensis
ATE497975T1 (de) Il-21-varianten
ES2545457T3 (es) Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
AR108277A2 (es) Péptidos inhibidores de fusión de hiv con propiedades biológicas mejoradas
PE20120914A1 (es) Compuestos glucagon activo de receptor de gip
PE20210376A1 (es) Peptidos y combinacion de peptidos de origen no canonico para el uso en la inmunoterapia contra diferentes tipos de cancer
SMT201300093B (it) Formulazioni di vwf ricombinante liofilizzate
AR064216A1 (es) Polipeptidos cristalinos de bacillus thuringiensis, polinucleotidos y composiciones de los mismos
CL2011002453A1 (es) Compuestos derivados de diazol u oxazol-pirrol o pirrolciclopropil condensados sustituidos, inhibidores de la función de la proteína ns5a codificada por el virus de la hepatitis c (vhc); composición farmacéutica; y su uso para el tratamiento de una infección por vhc.
HK1134507A1 (en) Peptide vaccines for cancers expressing tumor-associated antigens
AR069860A1 (es) Metodo para purificar un anticuerpo cd20
ES2570758T3 (es) Materiales y métodos para el control de enfermedades respiratorias en cánidos
AR049177A1 (es) Polipeptidos y conjugados de interferon-alfa
PE20160507A1 (es) Diferenciacion de celulas madre mesenquimales
AR085167A1 (es) Polipeptidos de porphyromonas gingivalis, metodo de tratamiento, uso, anticuerpo y kit
AR067980A1 (es) Peptidos de cdh3 y agentes que los comprenden
DOP2017000286A (es) Composiciones y metodos para tratar la enfermedad celiaca
AR053372A1 (es) Proteinas inmunologicas de lawsonia intracellularis
AR075933A1 (es) Composiciones polipeptidas y de inmunizacion conteniendo polipeptidos positivos gram y metodos de uso

Legal Events

Date Code Title Description
FA Application withdrawn